DSpace at RU >

Browsing by Author Labar, B.

Full Text	Issue Date	Title	Author(s)
	2012	EORTC Leukemia Group Achievements	Willemze, R.; Suciu, S.; Marie, J.P.; Karrasch, M.; Jansen, J.H., et al
	2011	The European LeukemiaNet: achievements and perspectives	Hehlmann, R.; Grimwade, D.; Simonsson, B.; Apperley, J.; Baccarani, M., et al
	2011	Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group	Lubbert, M.; Suciu, S.; Baila, L.; Ruter, B.H.; Platzbecker, U., et al
	2010	Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.	Labar, B.; Suciu, S.; Willemze, R.; Muus, P.; Marie, J.P., et al
	2009	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.	Mandelli, F.; Vignetti, M.; Suciu, S.; Stasi, R.; Petti, M.C., et al
	2007	Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study.	Labar, B.; Suciu, S.; Muus, P.; Willemze, R.; Marie, J.P., et al
	2004	Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.	Labar, B.; Suciu, S.; Zittoun, R.; Muus, P.; Marie, J.P., et al
	1997	A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)	Willemze, R.; Suciu, S.; Archimbaud, E.; Muus, P.; Stryckmans, P., et al
	1996	Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial	Keating, S.; Suciu, S.; Witte, T.J.M. de; Mandelli, F.; Willemze, R., et al
	1996	Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (06901) of the EORTC Leukemia Cooperative Group	Witte, T.J.M. de; Suciu, S.; Selleslag, D.; Labar, B.; Roozendaal, K.J., et al
	1995	Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia	Zittoun, R.; Mandelli, F.; Willemze, R.; Witte, T. de; Labar, B., et al